Crispr Therapeutics shares owned by Financial Perspectives
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Financial Perspectives
from 13F filings
Historical chart of Financial Perspectives investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Financial Perspectives consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Financial Perspectives
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $165k | 2.4k | 68.16 |
| 2023-12-31 | $144k | 2.3k | 62.60 |
| 2023-09-30 | $105k | 2.3k | 45.39 |
| 2023-06-30 | $129k | 2.3k | 56.14 |
| 2023-03-31 | $84k | 1.9k | 45.23 |
| 2022-12-31 | $76k | 1.9k | 40.65 |
| 2022-09-30 | $126k | 1.9k | 65.35 |
| 2022-06-30 | $108k | 1.8k | 60.77 |
| 2022-03-31 | $111k | 1.8k | 62.77 |
| 2021-12-31 | $128k | 1.7k | 75.78 |
| 2021-09-30 | $359k | 3.2k | 111.93 |
| 2021-06-30 | $527k | 3.3k | 161.89 |
| 2021-03-31 | $3.1M | 372k | 8.21 |
| 2020-12-31 | $274k | 1.8k | 153.11 |
| 2020-09-30 | $75k | 893 | 83.64 |
| 2020-06-30 | $22k | 304 | 73.49 |
| 2020-03-31 | $13k | 304 | 42.41 |
| 2019-12-31 | $19k | 304 | 60.90 |